SPURIOUS DRUGS IN INDIA: COMPARISON WITH EUROPE AND USA, SYSTEMATIC REVIEW

Main Article Content

S. UMESH
V. BALMURALIDHARA
K. C. SWATHI
H. V. RAGHUNANDAN

Abstract

India has a bigger problem of spurious and substandard drugs, which result in life threatening issues, financial loss of consumer and manufacturer and loss in trust on health system. In view of the fact that the conversion of credible medication into unsatisfactory medication can cause a number of adverse effects from mild to direct and to severe. To provide information regarding track and trace of  the spurious drugs in India in comparison with United States (USA), and Europe (EU). India is the largest producer to no-exclusive drugs. Also, potentially, 12-25% of all given prescriptions in India are contaminated, unsatisfactory or fake. The Directorate General of Health Administrations, Ministry of Health and Family Welfare, Legislature of India is united to decrease the spurious drugs. Legal foundation is discussed and  Guidelines for making a move on tests of not of standard quality in the light of upgraded punishments under the medications and beautifying agents (revision) act and future investigation plan and the comparison of spurious drugs in India, US and Europe. In   perspective on above perceptions and information acquired compared with US and Europe, we may conclude that, the state medication control associations made 13 rules to minimize the spurious and substandard drugs in India. Central drug standard control organization (CDSCO) done nationwide overview in India in 2017, from the review we come to know 3% sedates in India is unsatisfactory.

Keywords:
Spurious drugs, NSQ drugs, D&C act, indian regulatory system, policies.

Article Details

How to Cite
UMESH, S., BALMURALIDHARA, V., SWATHI, K. C., & RAGHUNANDAN, H. V. (2021). SPURIOUS DRUGS IN INDIA: COMPARISON WITH EUROPE AND USA, SYSTEMATIC REVIEW. Journal of Disease and Global Health, 14(1), 37-52. Retrieved from https://www.ikprress.org/index.php/JODAGH/article/view/6064
Section
Review Papers

References

Current scenario of spurious and substandard medicines in India. A Systematic Review; 2015.
Available:https://www.ijpsonline.com/articles/current-scenario-of-spurious-and-substandard-medicines-in-india-a-systematic-review.html

WHO. Medicines: Spurious/falsely-labeled/falsified/counterfeit (SFFC) medicines.
Available:http://www.who.int/mediacentre/factsheets/fs275/en/index.html . [Google Scholar]

Morris J, Philip S. Counterfeit medicines in less developed countries.
Available:http://www.policynetwork.net/sites/default/files/IPN_Counterfeits.pdf .

PSM. Counterfeit Drug Incident Encyclopedia. Partnership for Safe Medicines.
Available: http://www.safemedicines.org/counterfeit-drug-incident-encyclopedia.html .

Spurious Drugs / Counterfeit Drugs - An Overview
Available:https://www.pharmatutor.org/articles/spurious-drugs-counterfeit-drugs-overview

Ministry of Health and Family Welfare. Government of India, The Drugs and Cosmetics Act and Rules (Amendment); 2005.
Available: http://www.cdsco.nic.in/forms/contentpage1.aspx?lid=1888 . [Google Scholar]

DTAB-DCC - Central Drugs Standard Control Organisation
Available:https://cdsco.gov.in/opencms/opencms/en/dcc-dtab-committee

Drug Regulation in India
Available:https://thakur-foundation.org/TFF%20State%20Drug%20Regulatory%20Authorities%20Capability%20Assessment%20Report.pdf

Drugs and cosmetics act 1940 and rules 1945 - SlideShare
Available: https://www.slideshare.net/AnoopSingh200/drugs-and-cosmetics-act-1940-and-rules-1945

Ministry of Health and Family Welfare Shri J P Nadda.
Available:https://pib.gov.in/PressReleasePage.aspx?PRID=1549027

World Health Organization. Medicines regulation Regulatory systems in India An important global hub for medical products and technologies. WHO Drug Inf [Internet].
Available:https://www.who.int/medicines/publications/druginformation/issues/WHO_DI_31-3_RegSystemIndia.pdf?ua=1

Central Licences Approving Authority – cdsco
Available:https://cdsco.gov.in/opencms/opencms/en/Central-Licences-Approving-Authority/

Regulatory, Certifying And Licensing Authority In India - TaxGuru
Available:https://taxguru.in/corporate-law/regulatory-certifying-licensing-authority-india.html#:~:text=Central%20Drug%20Standard%20Control%20Organization,and%20cosmetics%20industry%20in%20India.&text=Whereas%2C%20for%20the%20sale%20of,Drug%20License%20Authority%20(SDLA).

Regulatory Body of India (CDSCO) Achievements | Morulaa
Available: https://morulaa.com/cdsco/achievements-of-the-cdsco-regulatory-body-of-india-2020/

e-Governance Portal | National Portal of India
Available:https://www.india.gov.in/e-governance-portal#:~:text=e%2DGovernance%20is%20understood%20as,the%20Government%20in%20a%20speedy%2C

Drugs and Cosmetics Act, 1940 - Legislative Department
Available: http://legislative.gov.in/sites/default/files/A1940-23.pdf

Public Notices - cdsco
Available:https://cdsco.gov.in/opencms/opencms/en/Notifications/Public-Notices/

Guidelines for taking action on samples of drugs declared spurious or not of standard quality in the light of enhanced penalties under the drugs and cosmetics (AMENDMENT) ACT; 2008.
Available:https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/Consumer_Section_PDFs/DCC_Guidelines_Spurious_Drugs.pdf

India's CDSCO flags 25 drugs as not of standard quality
Available:https://www.thepharmaletter.com/article/india-s-cdsco-flags-25-drugs-as-not-of-standard-quality

Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives.
Available:https://journals.sagepub.com/doi/abs/10.1177/2168479018812775